2,2-Dimethyl-4,7-dihydro-1,3-dioxepine, 95.0%, 100g

3-(Toluene-4-sulfonyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 95.0%, 10g

[1-(thiophen-2-yl)cyclohexyl]methanamine, 98%, 2.5g

L-Xylose, min.99%, pour la biochimie, 10 g, emballage en verre

Incubateur série BF avec mouvement d'air forcé (ventilateur), 59 l, BF 56, 1 pièce

(3'-Fluoro-[1,1'-biphenyl]-3-yl)methanamine, 95%, 500mg

Diethyl 3-aminopentanedioate hydrochloride, 97%, 250mg

2-Amino-1-(4-benzyl-piperazin-1-yl)-ethanonedihydrochloride, 98.0%, 1g

Ethyl 2-(3-nitrophenyl)acetate, 95.0%, 5g

1-Benzyl-5-methyl-1H-[1,2,3]triazole-4-carboxylic acid, 97.0%, 100mg

methyl 2-amino-5-nitro-4-(trifluoromethyl)benzoate, 95%, 250mg

3-[(4-Aminopiperidin-1-yl)methyl]benzonitrile dihydrochloride, 95.0%, 1g

(4-(5-Oxopyrazolidin-3-yl)phenyl)boronic acid, 97%, 100mg